top of page
Search

What the FTC's Covetrus-MWI Lawsuit Means for Pet Owners

2 days ago
10 min read

News analysis. Facts in this piece were last checked on November 18, 2026 (America/Toronto).


On November 13, 2026, the Federal Trade Commission and the attorneys general of 13 states sued in federal court to block Covetrus’s proposed acquisition of MWI Veterinary Supply, a deal reported as a $3.5 billion transaction. Official releases from New York, Minnesota, Michigan, and Oregon now spell out the coalition’s theory: the two distributors compete hard for clinic business, and the states allege that a merger would reduce that competition and could raise costs for clinics and pet owners.


This is a lawsuit, not a ruling. Covetrus disputes the government’s view of the market and says it will defend the deal in court. Nothing in the case has decided what any clinic will charge for an exam, a dental cleaning, or an emergency visit.


Key takeaways


  • The FTC and 13 states filed suit on November 13, 2026, in the U.S. District Court for the Southern District of New York, asking a court to stop Covetrus from buying MWI.

  • The case is about what clinics pay distributors for medicines, vaccines, and supplies. It is not a public list of clinic prices, and it is not a finding about your bill.

  • According to the New York Attorney General, the companies agreed to a temporary restraining order that prevents them from completing the merger before December 4, 2026. The coalition is also seeking a preliminary injunction, and a final ruling that the deal is illegal. As of November 18, 2026, that December date had not yet arrived, and no later official update was found.

  • Minnesota Attorney General Keith Ellison’s office stated that “veterinary costs have risen more than 40 percent this decade” and, in the same release, that “since 2021, the cost of pet veterinary care nationally has risen 43%.” Those are the AG’s claims. FareVet has not independently confirmed the figures, and they should not be read as a court finding or as a prediction that this merger will change your invoice.

  • You do not need a verdict to ask for a written estimate and to compare what is included. That is still the practical step.


Case status at a glance


Item

What official sources say (as of November 18, 2026)

Filed

November 13, 2026, U.S. District Court for the Southern District of New York (Michigan AG release)

Plaintiffs

The FTC and the attorneys general of Arizona, Arkansas, California, Colorado, Maine, Michigan, Minnesota, Nebraska, New York, North Carolina, Ohio, Oregon, and Texas

Defendants named in state releases

Covetrus, Inc.; MWI Veterinary Supply, Inc.; Covetrus’s owners Clayton, Dubilier & Rice LLC and TPG Inc.; MWI’s parent, Cencora Inc., is identified as the seller

Deal size

Reported as $3.5 billion

Legal claims (Michigan AG)

A two-count complaint: unfair method of competition under the FTC Act, and an illegal merger under Section 7 of the Clayton Act

Temporary restraining order

The companies agreed to a TRO that prevents them from completing the merger before December 4, 2026 (New York AG release)

What the coalition wants next

A preliminary injunction to halt the deal further, and ultimately a ruling that the merger is illegal and a permanent injunction

Company response

Covetrus says the lawsuit misreads how clinics buy supplies and that it is prepared to defend the transaction in court


What the states and the FTC allege


According to the New York Attorney General’s official release, Attorney General Letitia James joined the FTC and a coalition of 12 other states in suing to stop Covetrus, Inc. and its affiliates from acquiring MWI Veterinary Supply, Inc. The New York release describes the two companies as two of the three largest veterinary clinic distributors in the country, “one-stop shops” that supply equipment, supplies, and medications to independent clinics and to corporate practice groups.


Michigan Attorney General Dana Nessel’s November 17 release describes them as the two largest veterinary supply distributors in the country and confirms that the complaint was filed in the Southern District of New York. It says the merger, as alleged, “would lead to higher costs and decreased service quality to veterinary clinics and higher prices for pet owners.”


Oregon Attorney General Dan Rayfield, in a November 16 release, put the competition point in plain language: “Right now, these two companies compete hard for vet clinics’ business, and that keeps prices in check. If one consumes the other, that competition disappears, and it’s clinics and pet owners who end up paying for it.” That is an allegation in a pending case, not a court finding.


The shared theory, across these official releases, is that Covetrus and MWI compete on price, discounts, rebates, and service; that a merger would substantially reduce that competition; and that the combined firm would control more than 50% of the relevant markets, which the coalition says would violate the FTC Act and the Clayton Act. The New York release also says corporate practice groups often prefer one distributor that can serve all their locations and can typically purchase 65% to 90% of their supplies from a single company.


dvm360, citing the FTC complaint, reported that the case names Covetrus and its owners (Clayton, Dubilier & Rice LLC and TPG Inc.), that Covetrus agreed to acquire MWI from Cencora Inc., and that the Commission voted 2-0 to authorize staff to seek a permanent injunction. Those Commission-vote and complaint details are as reported by dvm360.


Those are claims in a complaint. A court has not found them proven.


The “more than 40 percent” cost claim


Minnesota Attorney General Keith Ellison’s November 16, 2026 release is the official source for the cost figures now circulating around this case. A summary line in that release states: “Veterinary costs have risen more than 40 percent this decade; merger would drive costs up further, lead to higher prices for veterinary clinics and pet owners.” In the body, the same office writes: “Since 2021, the cost of pet veterinary care nationally has risen 43%.”


Both sentences belong to the attorney general’s office. FareVet has not independently confirmed the 43% figure, or the “more than 40 percent this decade” wording, against a Bureau of Labor Statistics series or another primary data source for this article. “This decade” and “since 2021” are also not identical time windows, even though both appear in the same release. The second half of the summary line, that the merger “would drive costs up further,” is part of the plaintiffs’ theory about the deal. It is not a measurement of anyone’s vet bill, and it is not a ruling.


The Minnesota release also says that 54% of Minnesotans care for at least one pet, that Minnesota is the 17th-most expensive state in which to own a dog, and that from November 2024 through January 2025, 52% of U.S. pet owners reported they skipped needed veterinary care, with seven in 10 of those saying they could not afford it, it was not worth the cost, or both. Those statements are likewise attributed to the AG’s release. They are context the office used to explain why it joined the case. They are not findings in this lawsuit.


Where price comparison enters the case


The part of the case that will sound familiar to FareVet readers is not about comparing clinic fees. It is about clinics comparing distributor prices.


According to dvm360’s account of the complaint, the FTC alleges that Covetrus and MWI have competed aggressively on price, including through price cuts and rebates in Covetrus’s VetSuite program. The complaint, as reported there and in other complaint summaries, points to Vetcove, an online platform that lets veterinarians compare prices and use one distributor’s pricing to negotiate with the other. The complaint characterizes years of that rivalry as an “all-out price war.” Oregon’s release describes the same idea as “online tools that let vets compare the two companies’ prices.”


Vetcove, as described in that reporting, is a business-to-business purchasing tool for veterinary practices. It is not a consumer clinic-price site, and it is not a FareVet competitor. Naming it here is only to report what the complaint, as described by those sources, says about how the two distributors allegedly competed.


Daniel Guarnera, director of the FTC’s Bureau of Competition, said in remarks quoted by dvm360: “Veterinarians and millions of American pet owners benefit when veterinary distributors compete by offering lower prices and better service. This transaction will reduce competition in an already concentrated market and drive up prices for veterinarians and their customers.” He also said the two companies “are engaged in fierce head-to-head competition and Covetrus wants to eliminate its closest competitor rather than compete for veterinary clinic customers.”


The New York Attorney General’s release goes a step further on consumer impact. It says the two companies offer lower prices, rebates, and incentive packages, that corporate groups often play the two against each other, and that “these lower prices are often passed on to consumers in the form of more affordable care.” It also says that if the acquisition proceeds, “pet owners throughout New York and the nation are likely to pay higher prices for care.”


Treat that pass-through language as part of the plaintiffs’ theory. A clinic bill is made up of many things: the veterinarian’s time, staffing, facilities, diagnostics, medications, and supplies, among others. A change in what a clinic pays a distributor may or may not show up, dollar for dollar, on a specific invoice. This lawsuit has not measured that for your pet.


What Covetrus says


The day the suit was filed, Covetrus issued a statement, carried on PR Newswire, arguing that “this merger stands to improve the economics of veterinary practices” and that the FTC’s lawsuit “does not reflect an accurate understanding of how veterinarians actually buy the products they need.”


In that statement, Covetrus says clinics can buy from manufacturers (including, it says, direct sales without Covetrus or MWI), from other national and regional distributors, and from “online veterinary marketplaces” that, it says, are used by “in excess of 60% of U.S. practices” and let clinics compare prices and order from “40+ distributors and thousands of manufacturers.” It also says nearly all practices purchase directly from suppliers, that clinics routinely buy the same products from more than one supplier, and that retailers now sell some flea and tick treatments, pharmaceuticals, and pet foods directly to pet owners. Covetrus says it is “fully prepared to defend” the transaction in court.


Those are the company’s arguments. They have not been tested at trial in this case either. A fair reading of the news is that the government and the company disagree about how much choice clinics really have, and a judge will have to decide.


What happens next


The New York Attorney General’s office says the two companies have already agreed to a temporary restraining order that prevents them from completing the merger before December 4, 2026. The coalition is seeking a preliminary injunction to halt the merger further, and ultimately a ruling that the merger is illegal. Michigan’s release adds that the plaintiffs are seeking a permanent injunction.


Until a court rules, or the parties settle or abandon the deal, the acquisition is a proposed transaction under legal challenge. It should not be described as blocked for good, or as approved. The December 4 date, as of the November 18 check, is a temporary stop, not the end of the case. If a later official filing changes that status, this article should be updated before any staging.


What this means for pet owners today


You do not need to wait for an antitrust ruling to ask better questions about your bill.


If you are planning non-emergency care, ask for a written estimate that lists major line items and says what is included. Compare inclusions, not only the number at the bottom. Two clinics can quote very different totals for what sounds like the same service because one bundles diagnostics, anesthesia, or follow-up care and the other bills those separately. FareVet’s earlier guide, How to Compare Vet Prices Before Booking an Appointment, walks through that kind of comparison.


A government case about distributor competition does not replace that homework, and it does not tell you whether a particular clinic is “expensive” or “overpriced.” For planned care, local cost context still helps. In a true emergency, prioritize safe, timely care; price comparison is a planning tool, not a reason to delay urgent treatment.


FareVet’s job is unchanged: help you explore available veterinary cost information and compare estimates by what is included, not push you toward the cheapest clinic.




FAQ: The Covetrus-MWI lawsuit


Did the FTC already block the merger?


No. The FTC and 13 states filed a lawsuit on November 13, 2026, asking a court to stop the deal. According to the New York Attorney General, the companies agreed not to close before December 4, 2026, and the coalition is seeking a further injunction. That is not a final ruling.


Is this about the price of my dog’s exam or dental cleaning?


Not directly. The case is about competition between large distributors that sell medications, vaccines, surgical supplies, and other products to clinics. Plaintiffs allege that less competition at that level could eventually affect what pet owners pay. That is an allegation, not a finding about your clinic’s fee schedule.


Did veterinary costs officially rise “more than 40 percent this decade”?


That wording comes from the Minnesota Attorney General’s November 16, 2026 press release, which also says that since 2021, the cost of pet veterinary care nationally has risen 43%. FareVet has not independently confirmed those figures for this article. They are claims in a state release, not a finding in the lawsuit, and they should not be treated as a prediction of what this case will do to your bill.


Why does a price-comparison platform appear in the complaint?


As reported from the complaint, the FTC points to Vetcove, a platform veterinarians can use to compare distributor prices and negotiate. The agencies argue that this kind of comparison intensified competition between Covetrus and MWI. That is a description of clinic purchasing, not a claim about consumer clinic-price tools.


Will this lawsuit lower my vet bill?


No one can honestly promise that. FareVet is not claiming the case will reduce anyone’s veterinary invoice. If you want clearer costs today, ask for a written estimate and compare what is included.


A reminder about competition, not a verdict on your clinic


A federal lawsuit about veterinary supply distributors is a reminder that price competition matters, including when buyers can compare offers. It is not a substitute for a clear estimate at your clinic, and it has not decided what any pet owner will pay.


If you want a place to start, create a FareVet account and use Cost Search for local care context before a planned visit.




This guide is for planning and price transparency only. It is not veterinary medical advice, and it is not legal advice. Always discuss your pet’s individual medical needs with a licensed veterinarian.


Sources


  1. New York State Office of the Attorney General. “Attorney General James Sues Nation’s Largest Distributors of Veterinary Supplies to Ensure Fair Health Care Prices for Pet Owners.” November 13, 2026. https://ag.ny.gov/press-release/2026/attorney-general-james-sues-nations-largest-distributors-veterinary-supplies

  2. Minnesota Attorney General Keith Ellison. “Attorney General Ellison files lawsuit challenging veterinary supply distributor Covetrus’s $3.5 billion acquisition of rival MWI.” November 16, 2026. https://www.ag.state.mn.us/Office/Communications/2026/11/16_Covetrus.asp

  3. Michigan Department of Attorney General. “AG Nessel Joins FTC and States to Block Veterinary Supply Industry Merger.” November 17, 2026. https://www.michigan.gov/ag/news/press-releases/2026/11/17/ag-nessel-joins-ftc-and-states-to-block-veterinary-supply-industry-merger

  4. Oregon Department of Justice. “AG Rayfield Sues to Block Merger That Could Drive Up Vet Bills for Oregon Pet Owners.” November 16, 2026. https://www.doj.state.or.us/media-home/news-media-releases/ag-rayfield-sues-to-block-merger-that-could-drive-up-vet-bills-for-oregon-pet-owners/

  5. Caitlin McCafferty. “FTC sues to block Covetrus' merger with MWI Animal Health.” dvm360. Published November 13, 2026. https://www.dvm360.com/view/ftc-sues-to-block-covetrus-merger-with-mwi-animal-health

  6. Federal Trade Commission. “FTC Sues to Block Veterinary Supplies Distributor Covetrus’s $3.5 Billion Acquisition of Rival MWI.” Press release dated November 13, 2026 (title and URL as cited by dvm360 and Benzinga). https://www.ftc.gov/news-events/news/press-releases/2026/11/ftc-sues-block-veterinary-supplies-distributor-covetruss-35-billion-acquisition-rival-mwi

  7. Covetrus. “Covetrus Issues Statement on FTC Decision to Challenge Proposed Merger with MWI Animal Health.” PR Newswire. November 13, 2026. https://www.prnewswire.com/news-releases/covetrus-issues-statement-on-ftc-decision-to-challenge-proposed-merger-with-mwi-animal-health-302939180.html

  8. Reuters. “US FTC sues to block Cencora’s $3.5 billion sale of veterinary unit to Covetrus.” November 13, 2026. https://www.investing.com/news/stock-market-news/us-ftc-sues-to-block-cencoras-35-billion-sale-of-veterinary-unit-to-covetrus-5026197

  9. FareVet. “How to Compare Vet Prices Before Booking an Appointment.” https://www.farevet.com/post/how-to-compare-vet-prices-before-booking-an-appointment

 
 
 

Comments


bottom of page